Created at 2:31 p.m. Jun, 01, 2025
Author: tkcalibo
Related Note: 1474060051855 4
Rationale for change

This card is a little misleading, especially for someone reviewing the clotting cascade. Fibrinogen is the upstream product here so really disorders of fibrinolysis which involve plasmin overactivity deal with excessive degradation of serum fibrin. I think this is more clear than cleavage of serum fibrinogen which is a secondary processs.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pathoma::04_Hemostasis::03_Other_Disorders_of_Hemostasis #AK_Step2_v12::#Resources_by_rotation::Surgery::devirgilio_dorian::surgical_cxs #AK_Other::AnKing_Image::Aiman::Fibrinolytic_System #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::04_Fibrinolysis_and_Inhibitors_of_Hemostasis #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::19_Mixed_platelet_and_coagulation_disorders::*Disorders_of_Fibrinolysis #AK_Step2_v12::Original_decks::Dorian::surg::devirgilio::surgical_cxs #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::03_HIT_DIC_Disorders_of_Fibrinolysis #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step2_v12::!Shelf::Surgery::no_dupes #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Other::AnKing_Image::!Subjects::Hematology::Fibrinolytic_System